QA: Myovant Sciences Ltd. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001679082_2018_Myovant_Sciences_Ltd.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001679082')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001679082, Myovant Sciences Ltd.

  xvar xval
0 AssetsCurrent 184,164,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 906,000
3 remainder_Assets 208,000
4 LiabilitiesCurrent 18,337,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 165,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,357,000
9 ResearchAndDevelopmentExpense 43,500,000
10 remainder_Expenses 27,583,000
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 140,000
  yvar yval
0 Assets 185,278,000
1 Liabilities 18,502,000
2 Expenses 83,440,000
3 Revenues 0
4 StockholdersEquity 166,776,000
5 NetIncome -83,440,000
6 ComprehensiveNetIncome -83,370,000
7 BaseVar 143,680,000
8 EconomicCapitalRatio 2.00

Edgar->Model Mapping

Feature Distribution

Change over Time